A detailed history of Simplex Trading, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Simplex Trading, LLC holds 5,977 shares of PRTA stock, worth $93,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,977
Previous 2,267 163.65%
Holding current value
$93,360
Previous $46,000 115.22%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$16.73 - $24.79 $62,068 - $91,970
3,710 Added 163.65%
5,977 $99,000
Q2 2024

Jul 25, 2024

SELL
$19.54 - $26.15 $96,742 - $129,468
-4,951 Reduced 68.59%
2,267 $46,000
Q1 2024

Apr 25, 2024

BUY
$24.75 - $40.66 $178,645 - $293,483
7,218 New
7,218 $178,000
Q3 2022

Nov 04, 2022

BUY
$25.16 - $60.63 $514,144 - $1.24 Million
20,435 Added 632.47%
23,666 $1.43 Million
Q2 2022

Aug 03, 2022

BUY
$22.73 - $39.98 $72,031 - $126,696
3,169 Added 5111.29%
3,231 $87,000
Q3 2021

Oct 28, 2021

SELL
$48.2 - $78.89 $24,100 - $39,445
-500 Reduced 88.97%
62 $3,000
Q2 2021

Aug 12, 2021

SELL
$21.63 - $57.65 $176,825 - $471,288
-8,175 Reduced 93.57%
562 $28,000
Q1 2021

Apr 26, 2021

SELL
$11.0 - $28.24 $1,694 - $4,348
-154 Reduced 1.73%
8,737 $219,000
Q4 2020

Feb 02, 2021

BUY
$10.12 - $13.94 $20,533 - $28,284
2,029 Added 29.57%
8,891 $106,000
Q3 2020

Oct 14, 2020

BUY
$9.93 - $13.47 $55,220 - $74,906
5,561 Added 427.44%
6,862 $68,000
Q2 2020

Jul 13, 2020

SELL
$9.56 - $12.51 $30,362 - $39,731
-3,176 Reduced 70.94%
1,301 $13,000
Q1 2020

Apr 29, 2020

SELL
$7.54 - $15.77 $40,693 - $85,110
-5,397 Reduced 54.66%
4,477 $47,000
Q4 2019

Feb 05, 2020

SELL
$7.48 - $17.01 $55,711 - $126,690
-7,448 Reduced 43.0%
9,874 $156,000
Q3 2019

Oct 15, 2019

SELL
$6.89 - $10.45 $7,902 - $11,986
-1,147 Reduced 6.21%
17,322 $135,000
Q2 2019

Jul 26, 2019

BUY
$8.85 - $12.49 $161,937 - $228,542
18,298 Added 10700.58%
18,469 $195,000
Q1 2019

Apr 18, 2019

SELL
$10.32 - $14.49 $215,337 - $302,348
-20,866 Reduced 99.19%
171 $0
Q4 2018

Jan 16, 2019

BUY
$8.73 - $13.74 $7,630 - $12,008
874 Added 4.33%
21,037 $216,000
Q3 2018

Oct 23, 2018

BUY
$12.7 - $15.79 $239,941 - $298,320
18,893 Added 1487.64%
20,163 $263,000
Q2 2018

Jul 30, 2018

BUY
$10.99 - $44.21 $13,957 - $56,146
1,270 New
1,270 $18,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $733M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.